PDCD5-(1-26) is a N-terminal 26-residue fragment of human PDCD5 (programmed cell death 5) protein. PDCD5 is an important novel protein that regulates both apoptotic and nonapoptotic programmed cell death. The conformation of PDCD5 protein is a stable helical core consisting of a triple-helix bundle and two dissociated terminal regions. The N-terminal region is ordered and contains abundant secondary structure. Overexpression and purification of the N-terminal 26-residure fragment, PDCD5-(1-26), was performed in this study to better understand its tertiary structure. The spectroscopic studies using CD and hetero-and homo-nuclear NMR methods determine a stable α-helix formed by 
INTRODUCTION
PDCD5 (programmed cell death 5) is a protein that is involved in the regulation of cell apoptosis [1] . Studies of the biological activities of the PDCD5 protein have found that PDCD5 is expressed in tumour cells during apoptosis, and the expressed level of PDCD5 is significantly higher than that in normal cells. The expressed PDCD5 protein has been shown to traverse rapidly from the cytoplasm to the nucleus of cells and distribute uniformly in cells that undergo apoptosis [2] . The enhancement of TAJ [toxicity and JNK (c-Jun N-terminal kinase) inducer]/TROY-triggered paraptosis-like cell death by PDCD5 overexpression suggested that PDCD5 is an important regulator not only in apoptotic, but also in non-apoptotic, programmed cell death [3] .
The sequence of human PDCD5 shares significant similarity with the corresponding proteins of species ranging from yeast to mice [1, 4] . MTH1615 (MTH1615, Methanobacterium thermoautotrophicum 1615) is an orthologue of human PDCD5 in a thermophilic archaeon. The three-dimensional solution structure of the protease-resistant domain of MTH1615 protein was determined as a triple-helix bundle. However, the N-terminal 31 residues of MTH1615 protein were found as an unstructured region in solution, although this region was strongly predicted to be an α-helix [5] . In a previous study, we demonstrated that the conformation of human PDCD5 has three structural regions: a rigid core region and two dissociated terminal regions. The secondary chemical shifts and 15 N relaxation data collected for PDCD5 by heteronuclear NMR experiments suggested that the N-terminal residues of PDCD5 tend to form a stable α-helical structure [4] . The N-terminal sequence Ser 1 -Gly 22 of PDCD5 has eight amino acids identical with residues in the sequence Met 1 -Gln 20 of MTH1615 ( Figure 1 ). Thus it is interesting to determine experimentally whether the N-terminal residues of PDCD5 form an α-helix independently of the core of the protein.
In the present study, we have successfully expressed and purified PDCD5-(1-26), a fragment containing residues 1-26 of PDCD5. The three-dimensional conformation of PDCD5-(1-26) was studied by CD and multidimensional NMR methods. Analysis of the structural features of PDCD5-(1-26) suggests that the N-terminal peptide corresponding to the first 20 residues of PDCD5 can form a stable α-helix independently of the core of the protein. For an investigation of the functional entity of the N-terminal α-helix in PDCD5, an N-terminal-truncated PDCD5 consisting of residues Met 39 -Tyr 125 , PDCD5-(39-125), was purified. The apoptosis activity assay of PDCD5-(39-125) and PDCD5 was carried out.
MATERIALS AND METHODS

Expression and purification of PDCD5-(1-26) and PDCD5-(39-125)
For expression of PDCD5-(1-26), the fusion expression system used for expression of the intact human PDCD5 protein [6] was adopted. PDCD5-(1-26) was produced by mutation of Ala 27 of PDCD5 to a terminator in the expression plasmid pET-3d-HR52-PDCD5 by the QuikChange (Stratagene) method [7] . Two primers, primer 1 (5 -CGGCGATCCTGGTGATTAAGCCCAA-CAGGAAGCAAAGC-3 ) and primer 2 (5 -GCTTTGCTTCC-TGTTGGGCTTAATCACCAGGATCGCCG-3 ) were used as the Abbreviations used: HMQC, heteronuclear multiple-quantum correlation; HSQC, heteronuclear single-quantum correlation; MTH1615, Methanobacterium thermoautotrophicum 1615; NOE, nuclear Overhauser effect; PDCD5, programmed cell death 5; PS, phosphatidylserine; R.M.S.D., root mean square deviation. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (email address: jfw@sun5.ibp.ac.cn).
The atomic co-ordinates for PDCD5-(1-26) will appear in the Protein Data Bank under the accession code 1YYB. forward and reverse primers respectively. In the expression plasmid, there is a thrombin cleavage site (LVPR↓GS) between the fusion partner HR52, a His 6 -tagged N-terminal 52-residue fragment of staphylococcal nuclease R, and a target protein for removing the fusion partner. To purify the HR52-PDCD5-(1-26), a 10 cm × 1 cm column of chelating Sepharose Fast Flow charged with Ni 2+ was used. The flow rate was 1.0 ml/min. The recovered supernatant containing the overexpressed HR52-PDCD5-(1-26) was loaded on to the column. The column was then washed by the same procedure using the same buffers as described for purification of HR52-PDCD5. The digestion with thrombin (Sigma) was carried out on the column as described in the previous study [4] . The eluate containing PDCD5-(1-26) and thrombin was collected and precipitated by adding a 4-fold volume of cold (− 20
• C) ethanol. PDCD5-(1-26) can precipitate fully while the elute is kept overnight in 80 % (v/v) cold ethanol. The precipitate was collected by centrifugation (13 000 g for 15 min at 4
• C) and dissolved in 5 ml of water. Only PDCD5-(1-26) can refold well and has good solubility in water, since it is a small fragment. The solution was freeze-dried and stored at − 20
• C. As a result of thrombin cleavage, residue Met 1 in the sequence of PDCD5 was replaced by Gly 0 -Ser 1 , and the sequence of PDCD5-(1-26) consists of 27 amino acid residues.
For expression of PDCD5-(39-125), an N-terminal truncated fragment of PDCD5 containing residues Met 39 -Tyr 125 , the target gene was amplified from the plasmid pET-3d-HR52-PDCD5 and cloned using the NdeI and BamHI restriction sites of the vector pET-28b (Novagen) to generate expression plasmid pET-28b-PDCD5(39-125). Expression and purification of PDCD5-(39-125) were carried out using a similar method as described in the previous study for isolation of PDCD5 protein [4] . Three residues, Gly-Ser-His, are appended to the N-terminal residue Met 39 of PDCD5-(39-125) as a result of the thrombin cleavage.
Far-UV CD measurement
The far-UV CD spectrum for PDCD5-(1-26) at concentration of 0.125 mg/ml in 20 mM phosphate buffer (pH 6.5) was recorded on a Jasco 720 spectropolarimeter at room temperature (25 • C). Measurements were carried out with a 1-mm-pathlength cuvette over the wavelength range from 190 to 250 nm at 1 nm bandwidth. Typically, four scans were averaged for the collecting spectrum.
NMR spectroscopy
Samples of uniformly 15 N-labelled and unlabelled PDCD5-(1-26) were prepared for NMR studies. PDCD5-(1-26) (2.0-4.0 mM) was dissolved in H 2 O/ 2 H 2 O (9:1, v/v) containing 50 mM phosphate buffer (pH 6.5), 200 mM NaCl and 0.01 mM NaN 3 .
All NMR spectra were acquired at room temperature on a Bruker DMX 600 spectrometer equipped with a z-gradient tripleresonance cryo-probe. The two-dimensional 1 H-15 N R 1 , R 2 and NOE (nuclear Overhauser effect) spectra were obtained using standard pulse sequences with a water flip-back scheme [8] . 15 In the NOE experiment, a delay of 2.0 s was followed by 1 H saturation for 3.0 s. In the control experiment, the saturation period was replaced by a delay of equivalent duration (3.0 s). The two experiments were performed in an interleaved manner.
All NMR data were processed and analysed with FELIX98 (MSI/Accelrys). The data points in each indirect dimension were usually doubled by linear prediction before zero filling to the appropriate size [9] . A 70-90
• shifted square sine bell apodization was used for all dimensions before Fourier transformation. 1 H chemical shifts were referenced to internal DSS (2,2-dimethyl-2-silapentane-5-sulphonate). 15 N and 13 C chemical shifts were referenced indirectly [10] . Experimental R 1 , R 2 and NOE relaxation values, and the uncertainties associated with these parameters, were obtained by the same procedures as described in [4] .
Structure calculation
Based on the main-chain and side-chain resonance assignments, the NOE connectivities were identified for PDCD5-(1-26). The torsion angle restraints for PDCD5-(1-26) were generated with the program TALOS [11] . The structure calculations were carried out on Silicon Graphics station Onyx2 employing the program CNS1.1 [12] . A family of 200 structures was calculated, and the final family consisting of 20 conformers with the lowest target function was selected for structural analysis.
Induction and detection of cell apoptosis
HL-60 cells were cultured in complete medium consisting of RPMI 1640 medium supplemented with 15 % foetal bovine serum. For induction of apoptosis, HL-60 cells were washed twice in medium without serum. After the second wash, cells were resuspended and adjusted to 2 × 10 5 /ml. Cell suspensions were added into 24-well plates (0.5 ml for each well), and then both intact PDCD5 and PDCD5-(39-125) with different amounts (20 and 30 µg) were added to each well. BSA (20 µg) and etoposide (20 µg) were used as negative and positive controls respectively. The cells were harvested after treatment for 20 h and washed twice with PBS, followed by resuspending in 100 µl of annexin-V-binding buffer (10 mM Hepes, 140 mM NaCl, 2 mM MgCl 2 , 5 mM KCl and 2.5 mM CaCl 2 , pH 7.4). FITC-conjugated annexin V (10 µl) (Beijing Biosea Biotechnology Co.) was added according to the manufacturer's protocol. After incubation for 20 min at room temperature in the dark, another 400 µl of binding buffer was added, and samples were immediately analysed on 
RESULTS
Expression and purification of PDCD5-(1-26) and PDCD5-(39-125)
For structural analysis of PDCD5-(1-26), a better signal separation of NMR spectra is necessary for resonance assignments. The most important advantage of the multinuclear and multidimensional NMR experiments is to reduce signal degeneracy in NMR spectra. Stable-isotope-labelled PDCD5-(1-26) is then required for this study. For fulfilling this requirement, the expression plasmid pET-3d-HR52-PDCD5(1-26) with a small fusion partner His 6 -tagged HR52 was obtained. Expression and purification of PDCD5-(1-26) in Escherichia coli was analysed by 16.5 % tricine SDS/PAGE. The desired recombinant His 6 -tagged HR52-PDCD5-(1-26) was highly expressed in soluble form. PDCD5-(1-26) was successfully purified by twice precipitating the collected eluate after digestion with thrombin in 80 % (v/v) cold ethanol and followed by dissolving the precipitate in aqueous solution.
For investigation of the functional entity of the N-terminal α-helix in PDCD5, the N-terminal-truncated PDCD5 is required. PDCD5-(39-125) is a fragment of PDCD5 which was obtained by deletion of the N-terminal α-helix and a segment connecting the α-helix and triple-helix bundle of the protein. PDCD5-(39-125) was purified successfully, and the purification was analysed by following similar procedures as described above. 
Secondary chemical shifts of PDCD5-(1-26)
Analysis of the acquired heteronuclear NMR spectra provide Figure 4 . A 'dense' group of positive secondary chemical shifts 13 C α was observed for residues Ser 1 -Leu 17 . Secondary chemical shifts 1 H α provided negative values for all residues in sequence region Asp 3 -Leu 17 of PDCD5-(1-26). As has been indicated, 13 C α resonances of residues in α-helix experience a downfield shift of 2.0-4.0 p.p.m. compared with those in random coil, and 1 H α resonances shift upfield 0.15-0.60 p.p.m. [13, 14] . Therefore the segment composed of residues Asp 3 -Leu 17 of PDCD5-(1-26) is supposed to form an α-helical structure.
Determination of α-helix structure of PDCD5-(1-26)
Sequential and medium-range NOE connectivities were identified for the sequence of PDCD5- represent the characteristic NOE connectivity features of an α-helix structure. The NOE connectivity together with the chemical shift index obtained for PDCD5-(1-26) provided a preliminary identification of the α-helix structure in the fragment.
Calculation of the structures was carried out using a total of 223 distance and 19 torsion angle restraints. Distance and dihedral angle restraints for structure determination and structure statistics of the 20 lowest energy structures from the family of 200 calculated structures are listed in Table 1 . The superposition of 20 structures is shown in Figure 6 (A). Validation of geometries of the 20 structures was performed using the program PROCHECK-NMR [15] . Ramachandran map analysis showed that the majority of the dihedral angles were in the most favoured regions (85.7 %) and none were in the disallowed regions ( Table 1 ). The averaged R.M.S.D. (root mean square deviation) values for the segment involved in the α-helix structure were 0.23 + − 0.07 Å (1 Å = 0.1 nm) and 3.09 + − 0.96 Å for the backbone and all heavy atoms respectively, showing the well defined α-helix structure ( Figures 6B and 6C ).
Backbone dynamics of PDCD5-(1-26)
The values of the 1 H-15 N relaxation parameters, R 1 , R 2 and NOE are shown in Figure 7 . The overall pattern of variations in the R 1 , R 2 and NOE values as a function of residue number are similar to each other. The sequence dependence of the relaxation parameters for residues in sequence region Asp 3 -Ala 19 are fairly constant; in 19 form a stable ordered α-helix structure, and residues in the tail region remain highly mobile.
Apoptosis triggered by PDCD5-(39-125) and intact PDCD5
A biochemical hallmark of apoptotic cell death is the translocation of PS (phosphatidylserine) from the cytoplasmic surface of the cell membrane to the external cell surface [16] . Exposure of PS at the surface of apoptotic cells is easily determined by flow cytometry using fluorescence-labelled annexin V, which specifically binds PS [17] . To determine the respective apoptotic effects of PDCD5-(39-125) and intact PDCD5, we detected cell PS exposure stained by annexin-V-FITC. As shown in Figure 8 , the intact PDCD5 significantly enhanced the apoptosis of HL-60 cells induced by serum withdrawal. However, the effect on apoptosis-promoting of PDCD5-(39-125) is weaker than that of intact PDCD5. As a negative control, BSA had no effect on apoptosis-promoting of HL-60 cells induced by serum withdrawal. Since residues Lys 20 -Glu 38 of PDCD5 is a segment that connects the N-terminal α-helix and triple-helix bundle of PDCD5, weakening the effect on promoting cell apoptosis by PDCD5-(39-125) can be attributed to the deletion of the N-terminal α-helix in PDCD5.
DISCUSSION
Usually, peptides are shown to be flexible and have no ordered structure in solution owing to the lack of long-range interactions. Errors were derived from the uncertainties of the least-squares fit to the exponential decay function (for R 1 and R 2 ) or from the signal-to-noise ratios (for NOE).
The N-terminal residues of PDCD5 do not provide any long-range NOE contacts with the residues in the main part of the protein [4] . However, a stable well-formed α-helix was determined for residues Asp 3 -Ala 19 of fragment PDCD5-(1-26), and the tail region consisting of residues Lys 20 -Asp 26 is flexible and unstructured. The similar secondary chemical shifts and distribution of cross-peaks in the two-dimensional 1 H-15 N HSQC spectra obtained for residues of PDCD5-(1-26) to those obtained for corresponding residues of PDCD5 (Figures 3 and 4) suggest that the N-terminal residues of PDCD5 can form a stable α-helix structure independently of the core of the protein.
The sequence region Asp 3 -Ala 19 of PDCD5-(1-26) contains four leucine residues, three alanine residues, and eight charged and two polar amino acid residues. Figure 9(A) Figure 9 (A). If we spread up the front and the back sides of the helix, as shown in Figure 9 (B), we notice an interesting arrangement of the residues along the z-axis of the helix. In the sketched map for the front side of the helix, residues Glu 7 , Arg 10 , Agr 13 [22] . The left-hand representation is the front face and the right-hand one is the back face of potential surface. The surface ionic groups are coloured from blue to red in accordance with the electrostatic charge from most positive to most negative. panel, Figure 9B ). 11 and Gln 18 on the other side (right-hand panel, Figure 9B ). The back side of the helix provides a potential surface having hydrophilic/hydrophobic/hydrophilic character. In general, the back side of the helix has a surface that is more hydrophilic than the front side of the helix. Figure 9(C) shows the electrostatic potential surface on the front and back faces of the helix. Therefore the helix formed by PDCD5-(1-26) has a special character, which is different from the amphiphilic helical peptide. As is well known, the amphipathic character of amphiphilic helical peptide, defined as a α-helical domain containing opposite polar and non-polar 'face' [18] , is found in many helices that are associated with plasma membrane. The plasma-membraneassociated helices may be either the trans-membrane or in-plane helices in the membrane bilayer [19] .
Observation of the expression and localization of PDCD5 in the cell apoptosis process demonstrated the rapid translocation of PDCD5 to the nucleus of target cells undergoing apoptosis. The accumulation of PDCD5 in the nucleus precedes the chromosome DNA fragmentation and PS externalization [2] . However, how PDCD5 crosses the nuclear envelope and functions in the nucleus is still unclear. The N-terminal α-helix of PDCD5 has free orientation relating to the main part of the protein [4] . This may provide an environment for the N-terminal α-helix to serve as a functional entity independent of the PDCD5 protein. The apoptosis activity assay indicates that the deletion of the N-terminal α-helix of PDCD5 attenuates the apoptosis-promoting effects on HL-60 cells induced by serum withdrawal. This may correlate with different accumulations of PDCD5-(39-125) and intact PDCD5 in the nucleus. Thus it may be that the features of translocation of PDCD5-(39-125) and intact PDCD5 to the nucleus of cells are different. The N-terminal α-helix may play some role in the translocation of PDCD5 to the nucleus of target cells.
